MedPath

AI-powered Chatbot vs. Human Counselors in Smoking Cessation

Not Applicable
Not yet recruiting
Conditions
Smoking Cessation
Mobile Health
Interventions
Behavioral: 5A's/5R's advice
Other: Brief leaflet on health warning and smoking cessation
Other: Self-help smoking cessation booklet
Behavioral: AI-powered chatbot support
Behavioral: Counselor individual support
Registration Number
NCT06570070
Lead Sponsor
Beijing Normal University
Brief Summary

This study aims to explore the feasibility and preliminary effectiveness of AI-powered chatbot support in community smokers.

Detailed Description

Smoking cessation remains one of the most significant public health challenges worldwide, with tobacco use being a leading cause of preventable death and disease. Despite extensive efforts, the success rates of smoking cessation programs remain low, necessitating innovative approaches to support individuals in their journey to quit smoking. Recently, artificial intelligence (AI) has opened new possibilities in healthcare, including the development of AI-powered chatbots that assist individuals in behavior change, such as quitting smoking.

This randomized controlled trial aims to investigate the effectiveness of AI-powered chatbot that simulates human counselors, compared to traditional human counseling in promoting smoking cessation among community smokers. The AI-powered chatbot, equipped with personalized interactions and real-time support, offers scalable and cost-effective assistance, potentially making it an accessible alternative to human counseling. However, human counselors provide empathy, tailored advice, and a nuanced understanding of human behavior that AI may not fully replicate. This study will explore which approach is more effective in helping individuals achieve long-term smoking cessation.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. aged 18 and above, reside in Zhuhai for the next 6 months;
  2. smoke at least 1 cigarette or use e-cigarettes daily;
  3. Having a smartphone and a WeChat account, being able to use WeChat skillfully.
Exclusion Criteria
  1. Smokers who have communication barrier (either physically or cognitively);
  2. Smokers who are currently participating in other SC programmes or services

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AI support group5A's/5R's adviceAI-powered chatbot support+ 5A's/5R's advice + health warning leaflet+ Self-help booklet
Control group5A's/5R's advice5A's/5R's advice + health warning leaflet+ Self-help booklet
Counselor support groupBrief leaflet on health warning and smoking cessationCounselor individual support+ 5A's/5R's advice + health warning leaflet+ Self-help booklet
AI support groupAI-powered chatbot supportAI-powered chatbot support+ 5A's/5R's advice + health warning leaflet+ Self-help booklet
Counselor support groupSelf-help smoking cessation bookletCounselor individual support+ 5A's/5R's advice + health warning leaflet+ Self-help booklet
Counselor support groupCounselor individual supportCounselor individual support+ 5A's/5R's advice + health warning leaflet+ Self-help booklet
Counselor support group5A's/5R's adviceCounselor individual support+ 5A's/5R's advice + health warning leaflet+ Self-help booklet
AI support groupBrief leaflet on health warning and smoking cessationAI-powered chatbot support+ 5A's/5R's advice + health warning leaflet+ Self-help booklet
AI support groupSelf-help smoking cessation bookletAI-powered chatbot support+ 5A's/5R's advice + health warning leaflet+ Self-help booklet
Control groupBrief leaflet on health warning and smoking cessation5A's/5R's advice + health warning leaflet+ Self-help booklet
Control groupSelf-help smoking cessation booklet5A's/5R's advice + health warning leaflet+ Self-help booklet
Primary Outcome Measures
NameTimeMethod
Biochemical validated quit rate at 6 months follow-up6 months follow-up

The primary outcomes are biochemically validated quit rate (exhaled carbon monoxide \< 4 ppm or salivary cotinine \< 30 ng/ml)

Secondary Outcome Measures
NameTimeMethod
Self-reported 7-day point prevalence quit rate3 and 6 months follow-up

Self-reported 7-day point prevalence quit rate in the two groups

Biochemical validated quit rate at 3 months follow-up3 months follow-up

biochemically validated quit rate (exhaled carbon monoxide \< 4 ppm or salivary cotinine \< 30 ng/ml)

Consent ratebaseline

the percentage of eligible smokers who agree to participate out of the total number of eligible smokers

Smoking reduction rate3 and 6 months follow-up

Rate of smoking reduction by at least half of baseline amount in the two groups

Eligibility ratebaseline

the percentage of eligible smokers out of the total number of smokers screened

Percentage of Participant Engagement with E-Messages and Counselor Chats3 months follow-up

This outcome measures the percentage of participants who engage with the intervention by reading e-messages and responding to counselor chat messages at least once during the 3-month follow-up period.

Trial Locations

Locations (1)

Beijing Normal University

🇨🇳

Zhuhai, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath